🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This project introduces a novel methodology for the in-depth immunogenetic ...
Status
Enrolling By Invitation
Location
Institute of Applied Biosciences
Start Date
2024-03-01
Trial ID
NCT06646263
This is a single-arm, open-label, one center clinical study, to determine t...
Status
Unknown
Location
Ningbo No.5 Hospital (Ningbo Cancer Hospital)
Start Date
2017-06-07
Trial ID
NCT03179007
Treatments Being Tested
This phase II trial studies how well high-dose aldesleukin and ipilimumab w...
Status
Terminated
Location
Loyola University Medical Center
Start Date
2014-11-26
Trial ID
NCT02203604
Treatments Being Tested
TCR-T cell therapy experienced a breakthrough for treating tumors in recent...
Status
Unknown
Location
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2017-03-21
Trial ID
NCT03029273
Treatments Being Tested
Primary Objective: 1\. To describe the distribution of treatment regimens ...
Status
Completed
Location
Regeneron Research Facility
Start Date
2023-01-09
Trial ID
NCT05673967
Treatments Being Tested
This study proposes to evaluate 99mTc-CTR-FAPI SPECT imaging as a cost-effe...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-05-10
Trial ID
NCT07138729
Treatments Being Tested
Chimeric antigen receptor T cells (car-t) is one of the most effective ther...
Status
Completed
Location
No.3, Qingchun East Road
Start Date
2018-10-11
Trial ID
NCT04650724
Treatments Being Tested
This is a single center. single arm, open-label study to determine the safe...
Status
Unknown
Location
Beijing 302 Hospital of China
Start Date
2019-04-20
Trial ID
NCT03899415
Treatments Being Tested
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
To evaluate the safety and efficacy of T cell therapy with mutated TP53 R24...
Status
Not Yet Recruiting
Location
Department of Oncology, Shanghai General Hospital
Start Date
2024-09-24
Trial ID
NCT06619886
Treatments Being Tested